In order to explore the signalling mechanisms that may be associated with SEMA6B in cervical cancer, we performed differential gene expression analyses comparing SEMA6B high and low expression subgroups, from which we identified 71 significant DEGs (Supplementary Figure S8). This evidence concerns the gene SEMA6B and cervical carcinoma.